David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNSR
476
DELISTED
Finisar Corp
FNSR
| $23.4M | 0.04% |
1,284,429
+374,760
| +41% | +$5.39M |
|
477
BWX Technologies
BWXT
$14B
| $23.4M | 0.04% |
697,627
-300,931
| -30% | -$9.29M |
|
478
CALL
Freeport-McMoran
FCX
$111B
| $23.4M | 0.04% |
2,258,500
+467,100
| +26% | +$3.28M |
|
479
Intuitive Surgical
ISRG
$134B
| $23.3M | 0.04% |
348,345
-831,627
| -70% | -$51.5M |
|
|
CHS
480
DELISTED
Chicos FAS, Inc.
CHS
| $23.2M | 0.04% |
1,747,471
+1,463,725
| +516% | +$16.5M |
|
481
Home Depot
HD
$339B
| $23.1M | 0.04% |
+173,387
| New | +$21.6M |
|
|
LNKD
482
PUT
DELISTED
LinkedIn Corporation
LNKD
| $23M | 0.04% |
201,500
-43,600
| -18% | -$6.4M |
|
483
CBRE Group
CBRE
$44.4B
| $23M | 0.04% |
798,420
-1,522,976
| -66% | -$41.9M |
|
|
QEP
484
DELISTED
QEP RESOURCES, INC.
QEP
| $23M | 0.04% |
1,626,612
-1,297,444
| -44% | -$15M |
|
|
MIC
485
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $22.9M | 0.04% |
339,620
+209,824
| +162% | +$13.3M |
|
486
Abercrombie & Fitch
ANF
$5.01B
| $22.9M | 0.04% |
725,773
-1,065,713
| -59% | -$29.9M |
|
487
Green Plains
GPRE
$1.1B
| $22.7M | 0.04% |
1,425,238
+74,031
| +5% | +$1.19M |
|
488
Gildan
GIL
$10.3B
| $22.7M | 0.04% |
745,644
+377,500
| +103% | +$10M |
|
|
AGN.PRA
489
DELISTED
Allergan plc
AGN.PRA
| $22.7M | 0.04% |
24,800
-30,700
| -55% | -$29.4M |
|
490
Kimberly-Clark
KMB
$37.3B
| $22.7M | 0.04% |
168,670
-162,713
| -49% | -$21.2M |
|
491
EOG Resources
EOG
$79.9B
| $22.7M | 0.04% |
312,211
-338,950
| -52% | -$23.4M |
|
492
PUT
Nike
NKE
$61B
| $22.6M | 0.04% |
368,400
-137,000
| -27% | -$8.27M |
|
493
Conagra Brands
CAG
$8B
| $22.5M | 0.04% |
647,891
+397,288
| +159% | +$12.9M |
|
494
Digital Realty Trust
DLR
$68.5B
| $22.5M | 0.04% |
254,120
+43,187
| +20% | +$3.5M |
|
495
PUT
American Express
AXP
$232B
| $22.5M | 0.04% |
365,800
+186,600
| +104% | +$10.9M |
|
|
VAL
496
DELISTED
Valspar
VAL
| $22.5M | 0.04% |
209,864
-97,856
| -32% | -$8.08M |
|
497
PUT
BP
BP
$114B
| $22.5M | 0.04% |
884,360
-357,025
| -29% | -$9.01M |
|
|
VXX
498
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $22.4M | 0.04% |
+79,330
| New | +$29.9M |
|
499
Leidos
LDOS
$17.4B
| $22.3M | 0.04% |
442,554
+67,789
| +18% | +$3.23M |
|
|
LM
500
DELISTED
Legg Mason, Inc.
LM
| $22.2M | 0.04% |
640,790
+90,562
| +16% | +$2.84M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.